Sequoia Economic Infrastructure Income Fund Limited Early Release of Placing Price

Sequoia Economic Infrastructure Income Fund Limited

Sequoia Economic Infrastructure Income Fund Limited (LON: SEQI) announced today that further to the announcement on 2 September 2019 in relation to a proposed placing of up to 125,000,000 new ordinary shares of no par value in the Company, the Board of Directors of the Company announces that the issue price of the New Shares will be 111.00 pence per New Share. At the Placing Price, assuming that 125,000,000 New Shares are issued, the gross proceeds of the Placing will be £138,750,000.

The Placing Price represents a discount of approximately 5.0 per cent. to the closing share price on 30 August 2019 of 116.80 pence, the last business day prior to the initial announcement of the Placing.

As announced earlier today, the Company’s unaudited cum-income NAV per ordinary share as at 30 August 2019 was 104.62 pence (the “NAV”). The Placing Price represents a premium of approximately 6.1 per cent. to the NAV. The Placing will be NAV accretive for existing shareholders.

The expected closing date of the Placing remains 1:00pm on 19 September 2019.

Share on:
Find more news, interviews, share price & company profile here for:

    JPMorgan European Discovery Trust reports strong performance uplift in latest factsheet

    JPMorgan European Discovery Trust reported a 5.37% share price rise in July 2025, outpacing NAV and its benchmark. Year-to-date, the share price is up 34.17%, supported by strong small-cap performance and effective stock selection.

    Golden Matrix reports record August revenue of $17.8m, up 18% year-on-year

    Golden Matrix posted record August revenues of $17.8m, up 18% from last year, with July revenues also rising 24% to $15.7m. Strong performance came from Meridianbet’s sports betting and RKings’ tournaments, positioning the group for record Q3 results.

    HUTCHMED to present new lung cancer and oncology data at WCLC and CSCO 2025

    HUTCHMED announced that updated data on savolitinib in NSCLC and other pipeline compounds will be presented at the World Conference on Lung Cancer in Barcelona and the CSCO Annual Meeting in China this September. Presentations include studies on savolitinib, surufatinib, fruquintinib and first-in-human results for HMPL-653.

    Surface Transforms appoints Paul Marr as Non-Executive Director

    Surface Transforms has appointed Paul Marr to its Board as Non-Executive Director. Marr brings over 40 years of global automotive manufacturing and operational leadership experience, including senior roles at General Motors and other international groups.

    Avation signs 12-year lease for ATR 72-600 with Cambodian airline

    Avation has agreed a twelve-year lease with a Cambodian carrier for a new ATR 72-600, the second of ten aircraft ordered in 2024. Delivery is scheduled for February 2026.

    Tern Plc delivers stronger interim results with reduced loss and portfolio growth

    Tern Plc reported improved interim results for the six months to 30 June 2025, with a 64% reduction in loss, disciplined cost control, and a new strategic investment in Sure Ventures plc. The company also strengthened portfolio support through successful fundraises.

      Search

      Search